栄研化学の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/03/11 | 1,725 | 1,726 | 1,697 | 1,706 | -36 | -2.1% | 66,700 |
| 2022/03/10 | 1,742 | 1,748 | 1,730 | 1,742 | +40 | +2.4% | 71,300 |
| 2022/03/09 | 1,703 | 1,718 | 1,679 | 1,702 | -1 | -0.1% | 103,500 |
| 2022/03/08 | 1,698 | 1,737 | 1,693 | 1,703 | +3 | +0.2% | 103,300 |
| 2022/03/07 | 1,698 | 1,710 | 1,664 | 1,700 | -10 | -0.6% | 113,400 |
| 2022/03/04 | 1,735 | 1,736 | 1,710 | 1,710 | -12 | -0.7% | 71,300 |
| 2022/03/03 | 1,770 | 1,770 | 1,722 | 1,722 | -16 | -0.9% | 82,900 |
| 2022/03/02 | 1,751 | 1,756 | 1,733 | 1,738 | -30 | -1.7% | 90,100 |
| 2022/03/01 | 1,752 | 1,774 | 1,746 | 1,768 | +28 | +1.6% | 87,100 |
| 2022/02/28 | 1,699 | 1,740 | 1,693 | 1,740 | +30 | +1.8% | 123,100 |
| 2022/02/25 | 1,691 | 1,714 | 1,686 | 1,710 | +11 | +0.6% | 138,700 |
| 2022/02/24 | 1,711 | 1,735 | 1,688 | 1,699 | -17 | -1% | 122,500 |
| 2022/02/22 | 1,719 | 1,725 | 1,700 | 1,716 | -23 | -1.3% | 86,400 |
| 2022/02/21 | 1,728 | 1,745 | 1,721 | 1,739 | -17 | -1% | 64,800 |
| 2022/02/18 | 1,720 | 1,759 | 1,718 | 1,756 | +13 | +0.7% | 62,800 |
| 2022/02/17 | 1,771 | 1,777 | 1,743 | 1,743 | -33 | -1.9% | 84,100 |
| 2022/02/16 | 1,790 | 1,794 | 1,766 | 1,776 | +20 | +1.1% | 90,400 |
| 2022/02/15 | 1,785 | 1,796 | 1,751 | 1,756 | -33 | -1.8% | 106,100 |
| 2022/02/14 | 1,802 | 1,806 | 1,782 | 1,789 | -49 | -2.7% | 115,600 |
| 2022/02/10 | 1,840 | 1,842 | 1,825 | 1,838 | +4 | +0.2% | 74,500 |
| 2022/02/09 | 1,823 | 1,841 | 1,805 | 1,834 | +28 | +1.6% | 138,900 |
| 2022/02/08 | 1,803 | 1,827 | 1,801 | 1,806 | +18 | +1% | 146,300 |
| 2022/02/07 | 1,795 | 1,804 | 1,771 | 1,788 | -8 | -0.4% | 131,100 |
| 2022/02/04 | 1,805 | 1,815 | 1,771 | 1,796 | +5 | +0.3% | 130,700 |
| 2022/02/03 | 1,762 | 1,802 | 1,751 | 1,791 | +23 | +1.3% | 165,000 |
| 2022/02/02 | 1,709 | 1,775 | 1,707 | 1,768 | +82 | +4.9% | 286,700 |
| 2022/02/01 | 1,735 | 1,759 | 1,684 | 1,686 | -25 | -1.5% | 249,400 |
| 2022/01/31 | 1,669 | 1,725 | 1,652 | 1,711 | -53 | -3% | 362,300 |
| 2022/01/28 | 1,761 | 1,767 | 1,736 | 1,764 | +20 | +1.1% | 164,200 |
| 2022/01/27 | 1,805 | 1,815 | 1,732 | 1,744 | -49 | -2.7% | 158,000 |
| 2022/01/26 | 1,770 | 1,807 | 1,770 | 1,793 | +24 | +1.4% | 68,200 |
| 2022/01/25 | 1,823 | 1,823 | 1,760 | 1,769 | -53 | -2.9% | 102,400 |
| 2022/01/24 | 1,773 | 1,824 | 1,771 | 1,822 | +22 | +1.2% | 102,900 |
| 2022/01/21 | 1,781 | 1,800 | 1,772 | 1,800 | -3 | -0.2% | 88,900 |
| 2022/01/20 | 1,798 | 1,822 | 1,787 | 1,803 | +22 | +1.2% | 70,300 |
| 2022/01/19 | 1,806 | 1,824 | 1,773 | 1,781 | -54 | -2.9% | 139,000 |
| 2022/01/18 | 1,852 | 1,861 | 1,826 | 1,835 | -14 | -0.8% | 78,900 |
| 2022/01/17 | 1,874 | 1,875 | 1,843 | 1,849 | -25 | -1.3% | 94,800 |
| 2022/01/14 | 1,900 | 1,900 | 1,856 | 1,874 | +10 | +0.5% | 192,400 |
| 2022/01/13 | 1,912 | 1,912 | 1,864 | 1,864 | -48 | -2.5% | 102,000 |
| 2022/01/12 | 1,906 | 1,914 | 1,893 | 1,912 | +34 | +1.8% | 75,900 |
| 2022/01/11 | 1,874 | 1,878 | 1,855 | 1,878 | +22 | +1.2% | 66,500 |
| 2022/01/07 | 1,867 | 1,880 | 1,843 | 1,856 | ±0 | ±0% | 127,000 |
| 2022/01/06 | 1,887 | 1,895 | 1,856 | 1,856 | -45 | -2.4% | 121,000 |
| 2022/01/05 | 1,947 | 1,947 | 1,900 | 1,901 | -41 | -2.1% | 107,400 |
| 2022/01/04 | 1,941 | 1,945 | 1,917 | 1,942 | +12 | +0.6% | 120,100 |
| 2021/12/30 | 1,927 | 1,936 | 1,916 | 1,930 | ±0 | ±0% | 28,400 |
| 2021/12/29 | 1,906 | 1,930 | 1,901 | 1,930 | +27 | +1.4% | 92,500 |
| 2021/12/28 | 1,906 | 1,906 | 1,880 | 1,903 | +20 | +1.1% | 102,800 |
| 2021/12/27 | 1,897 | 1,905 | 1,883 | 1,883 | -24 | -1.3% | 90,500 |
851～
900
件表示中 / 7027件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 栄研化 | 243,700円 | +4.1% | -3.1% | 2.38% | 21.17倍 | 1.85倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| 持田薬 | 311,000円 | +5.1% | -7.0% | 2.57% | 20.42倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ゼリア新薬 | 202,300円 | +3.1% | -6.5% | 2.37% | 9.39倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 杏林製薬 | 151,900円 | -2.4% | -52.3% | 3.75% | 18.18倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ネクセラファーマ | 92,500円 | +20.3% | - | 0.00% | 164.01倍 | 1.27倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
